Skip to main content
. Author manuscript; available in PMC: 2009 Oct 23.
Published in final edited form as: Oral Dis. 2008 Feb 14;14(3):206–216. doi: 10.1111/j.1601-0825.2008.01440.x

Figure 1.

Figure 1

Targets of biologic therapies: Mab, monoclonal antibody/biologic agent. (A) Biologic agent targeting membrane-bound molecules. Examples: anti-TNF (infliximab, adalimumab), anti-IL-6 receptor (tocilizumab), IL-1 receptor antagonist (anakinra), CTLA4 Ig (abatacept). (B) Biologic agent targeting soluble molecules. Examples: anti-TNF (infliximab, adalimumab), anti-BLyS (belimumab). TNF, tumor necrosis factor; IL, interleukin; CD, cluster of differentiation; BLyS, B lymphocyte stimulator